Stilt Legs Disease Affects One in Ten Women in Switzerland

Lipoedema is estimated to affect one in ten women in Switzerland, according to reporting by Watson published on May 16, 2026. The condition, sometimes referred to colloquially in French-speaking regions as the pillar leg disease, is a chronic health issue characterized by an abnormal and symmetrical accumulation of adipose tissue.

Unlike general obesity, lipoedema involves the buildup of fat that is typically resistant to traditional weight-loss efforts, such as calorie-restricted diets or increased physical exercise. The fat deposits most commonly occur in the legs and hips, though they can also manifest in the arms.

The condition is often identified by a disproportionate body shape, where the lower body remains significantly larger than the upper body. A distinguishing physical characteristic is that the fat accumulation often stops abruptly at the ankles, leaving the feet unaffected.

Symptoms and Physical Impact

Lipoedema is not merely a cosmetic concern but a medical condition that can cause significant physical distress. Affected individuals often experience pain and a feeling of heaviness in the limbs, which can make daily activities and mobility difficult.

The tissue associated with lipoedema is frequently sensitive to pressure. This sensitivity often leads to easy bruising and swelling, further complicating the physical management of the condition.

Challenges in Diagnosis

One of the primary hurdles for women with lipoedema is the frequency of misdiagnosis. Because the primary symptom is the accumulation of fat, many healthcare providers initially mistake the condition for obesity or general weight gain.

This misidentification often leads to patients being advised to lose weight through diet and exercise, which are generally ineffective for treating the specific fat deposits caused by lipoedema. This gap in diagnosis can lead to prolonged periods where patients do not receive appropriate care or understanding of their condition.

The disparity in diagnosis has been linked to a broader historical trend in medical research where conditions exclusively or primarily affecting women have been overlooked or understudied compared to health issues affecting men.

Causes and Hormonal Triggers

While the exact cause of lipoedema remains unknown, medical evidence suggests that hormones play a critical role in its development and progression. The condition is typically triggered or exacerbated during significant hormonal shifts in a woman’s life.

Key periods of hormonal change that are associated with the onset or worsening of lipoedema include:

• Puberty
• Pregnancy
• Menopause

In addition to hormonal influences, research indicates that genetic factors may predispose certain women to the condition. Inflammatory factors are also believed to contribute to the abnormal development of adipose tissue in those affected.

Management and Outlook

Because the fat in lipoedema does not respond to standard weight-loss methods, management focuses on reducing symptoms and preventing the condition from progressing into lymphedema, a more severe form of swelling caused by lymph fluid buildup.

Common management strategies include the use of compression garments and manual lymphatic drainage to manage swelling and reduce pain. In some cases, specialized surgical interventions may be used to remove the affected adipose tissue, although these are typically reserved for severe cases where mobility is significantly impaired.